TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ZLAB

Zai Lab Ltd

Healthcare · Biotechnology

25.70$ +2.8% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement ZLAB
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
– – – 33.7% 28.9% 489.1% 36.2% 34.4% 35.9% 37.1% 41.5%
– – – 66.3% 71.1% -389.1% 63.8% 65.6% 64.1% 62.9% 58.5%
– – – 92,913.2% 1,095.3% 454.9% 397.3% 133.2% 99.7% 58.8% 48.0%
– – – 16,667.1% 540.7% 227.4% 151.6% 91.8% 105.6% 74.9% 60.3%
– – – 109,580.3% 1,636.0% 227.4% 548.9% 253.6% 201.5% 133.6% 107.1%
– – – -109,514.0% -1,564.9% -616.4% -485.1% -188.0% -137.4% -70.7% -48.6%
– – – 30.6% 2.3% 0.4% 2.3% 6.8% 5.5% 0.6% 1.1%
– – – -106,980.5% -1,496.5% -549.3% -487.4% -206.1% -125.5% -64.4% -38.8%
– – – 2,564.2% -84.4% 62.0% 0.7% 0.1% 14.6% – -0.6%
– – – -107,433.6% -1,412.2% -549.3% -488.2% -206.1% -125.5% -64.4% -38.1%
– – – -106,949.8% -1,535.9% -607.0% -477.8% -202.2% -136.9% -58.8% -34.4%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?